Abstract

Spinocerebellar ataxia 36 (SCA36) is a type of repeat expansion-related neurodegenerative disorder identified a decade ago. Like other SCAs, the symptoms of SCA36 include the loss of coordination like gait ataxia and eye movement problems, but motor neuron-related symptoms like muscular atrophy are also present in those patients. The disease is caused by a GGCCTG hexanucleotide repeat expansion in the gene Nop56, and the demographic incidence map showed that this disease was more common among the ethnic groups of Japanese and Spanish descendants. Although the exact mechanisms are still under investigation, the present evidence supports that the expanded repeats may undergo repeat expansion-related non-AUG-initiated translation, and these dipeptide repeat products could be one of the important ways to lead to pathogenesis. Such studies may help develop potential treatments for this disease.

Highlights

  • Frontiers in GeneticsSpinocerebellar ataxia 36 (SCA36) is a type of repeat expansion-related neurodegenerative disorder identified a decade ago

  • Spinocerebellar ataxias (SCAs) are a group of autosomal dominant neurodegenerative diseases that share the key features of progressive cerebellar ataxia

  • In silico studies indicated both GGCCTG repeats seen in Spinocerebellar ataxia 36 (SCA36), and GGGGCC repeats seen in C9ALS/FTD can form a regional DNA/RNA structure called guanine quadruplex (Zhang et al, 2018)

Read more

Summary

Frontiers in Genetics

Spinocerebellar ataxia 36 (SCA36) is a type of repeat expansion-related neurodegenerative disorder identified a decade ago. Like other SCAs, the symptoms of SCA36 include the loss of coordination like gait ataxia and eye movement problems, but motor neuron-related symptoms like muscular atrophy are present in those patients. The exact mechanisms are still under investigation, the present evidence supports that the expanded repeats may undergo repeat expansion-related non-AUG-initiated translation, and these dipeptide repeat products could be one of the important ways to lead to pathogenesis. Such studies may help develop potential treatments for this disease

INTRODUCTION
Incidence in Japan and Other Asian Areas
Incidence in Spain and Other European Areas
Incidence in the United States
CLINICAL SYMPTOMS
Common Movement Coordination Signs
Common Motor Neuron Signs
Other Nervous System Function Impairment
MOLECULAR DIAGNOSIS
GENETIC ANTICIPATION
MOLECULAR PATHOGENESIS
ATTEMPTS OF THERAPEUTIC INTERVENTIONS
Findings
CONCLUSION AND FUTURE DIRECTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call